These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22310940)

  • 21. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is fatigue associated with cognitive dysfunction in early Parkinson's disease?
    Kluger BM; Pedersen KF; Tysnes OB; Ongre SO; Øygarden B; Herlofson K
    Parkinsonism Relat Disord; 2017 Apr; 37():87-91. PubMed ID: 28202373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson's disease patients.
    Yang HJ; Kim YE; Yun JY; Ehm G; Kim HJ; Jeon BS
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1419-22. PubMed ID: 25446342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Giuntini M; Mazzucchi S; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Clin Exp Neuropsychol; 2013; 35(2):124-31. PubMed ID: 23216295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
    Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
    Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    J Neurol; 2013 Feb; 260(2):438-44. PubMed ID: 22911513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
    Jones JD; Burroughs M; Apodaca M; Bunch J
    Neuropsychology; 2020 Jan; 34(1):24-30. PubMed ID: 31219297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease.
    Kang SH; Lee HM; Seo WK; Kim JH; Koh SB
    J Neurol Sci; 2016 Sep; 368():374-8. PubMed ID: 27538667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.
    Sommerauer M; Fedorova TD; Hansen AK; Knudsen K; Otto M; Jeppesen J; Frederiksen Y; Blicher JU; Geday J; Nahimi A; Damholdt MF; Brooks DJ; Borghammer P
    Brain; 2018 Feb; 141(2):496-504. PubMed ID: 29272343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson's disease motor subtypes? Findings from a 5-year prospective study.
    Arie L; Herman T; Shema-Shiratzky S; Giladi N; Hausdorff JM
    J Neurol; 2017 Oct; 264(10):2149-2157. PubMed ID: 28879438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics.
    Sollinger AB; Goldstein FC; Lah JJ; Levey AI; Factor SA
    Parkinsonism Relat Disord; 2010 Mar; 16(3):177-80. PubMed ID: 19939721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease.
    Picillo M; Amboni M; Erro R; Longo K; Vitale C; Moccia M; Pierro A; Santangelo G; De Rosa A; De Michele G; Santoro L; Orefice G; Barone P; Pellecchia MT
    J Neurol; 2013 Nov; 260(11):2849-55. PubMed ID: 23989344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.
    Mamikonyan E; Moberg PJ; Siderowf A; Duda JE; Have TT; Hurtig HI; Stern MB; Weintraub D
    Parkinsonism Relat Disord; 2009 Mar; 15(3):226-31. PubMed ID: 18595765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives.
    Baig F; Lawton M; Rolinski M; Ruffmann C; Nithi K; Evetts SG; Fernandes HR; Ben-Shlomo Y; Hu MT
    Mov Disord; 2015 Nov; 30(13):1759-66. PubMed ID: 26179331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.
    Aarsland D; Bronnick K; Williams-Gray C; Weintraub D; Marder K; Kulisevsky J; Burn D; Barone P; Pagonabarraga J; Allcock L; Santangelo G; Foltynie T; Janvin C; Larsen JP; Barker RA; Emre M
    Neurology; 2010 Sep; 75(12):1062-9. PubMed ID: 20855849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric Symptoms in the Initial Motor Stage of Parkinson's Disease.
    Stanković I; Stefanova E; Tomić A; Lukić MJ; Stojković T; Marković V; Stojmenović GM; Kresojević N; Svetel M; Kostić V
    J Neuropsychiatry Clin Neurosci; 2016; 28(3):205-10. PubMed ID: 26900739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.